HYPMY (Hypera) Common Stock : $1,591 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Hypera Common Stock?

Hypera's quarterly common stock declined from Jun. 2024 ($1,802 Mil) to Sep. 2024 ($1,753 Mil) and declined from Sep. 2024 ($1,753 Mil) to Dec. 2024 ($1,591 Mil).

Hypera's annual common stock increased from Dec. 2022 ($854 Mil) to Dec. 2023 ($914 Mil) and increased from Dec. 2023 ($914 Mil) to Dec. 2024 ($1,591 Mil).

Hypera Common Stock Historical Data

The historical data trend for Hypera's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Common Stock Chart

Hypera Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

870.44

791.90

853.72

913.94

1,590.87

Hypera Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															913.94	1,816.87	1,802.03	1,752.66	1,590.87

Hypera Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Hypera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (OTCPK:HYPMY) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

HM6A:Germany HYPE3:Brazil

Address

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120

Website

https://www.hypermarcas.com.br

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.